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Revision Total Knee Arthroplasty is often complicat-
ed by large bone defects in the distal femur and prox-
imal tibia. These defects can be managed in a variety 
of ways including the use of allograft bone. The pur-
pose of this study was to retrospectively evaluate the 
clinical outcome of revision total knee arthroplasty 
cases where allograft bone was used.
Thirty revision TKA’s (27 patients) performed between 
1994 and 2009 were followed for a mean of 5 years (1-
14 years).  Preoperative  bone  defects  were  classified 
using the Anderson Orthopaedic Research Institute 
classification system. Patient follow-up entailed calcu-
lation of the Knee Society Score and radiological as-
sessment of the revision joint replacement in addition 
to review of complications. 
Kaplan Meier analysis predicted survivorship at 
5 years as 93%, with further revision surgery as end 
point. The average Knee Society Score was 76.4, with 
19 (63%) of knees scoring “excellent” results, 4 (14%) 
“good”, 1 (3%) “fair” and 6 (20%) were “poor”. The 
overall complication rate was 23.3%. Radiological 
 lucency was demonstrated on recent radiographs for 
one patient. Three knees were re-revised at 1 year, 
6 years and 8 years respectively. 
Our study demonstrates promising short to medium 
term results with the use of allograft bone in revision 
total  knee  replacement  presenting  with  significant 
bone loss. 
Keywords : revision knee arthroplasty ; allograft bone 
grafts.
INTRODUCTION
Some cases of revision total knee arthroplasty 
(TKA) present with large bone defects. These can 
be secondary to osteolysis, implant migration, or 
bone loss due to multiple revisions. Large bone 
 defects can be managed using megaprostheses, 
 custom made implants, metal augments and stems, 
cement fillers, or allograft bone. The method chosen 
depends on multiple factors, including size and type 
of defect, cause of bone loss and patient specific 
factors, including age. 
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There are several advantages for using bone al-
lograft to fill bone defects, including the ability to 
fashion the allograft to fit the defect. This enables 
restoration of a good anatomical framework in 
which to place the metallic prosthesis. Restoration 
of bone stock is advantageous in the possible event 
that further operative management be needed at a 
later stage. Although allograft use requires a great 
deal of preoperative planning, fashioning of the 
graft occurs intraoperatively, making this a dynamic 
process. It is often noted that estimation of defect 
size from radiological studies preoperatively under-
estimates the true bone defect size. Dynamic fash-
ioning hence allows more accurate and complete 
filling of the bone loss. Bulk allograft is available as 
proximal tibia and distal femur, and femoral head, 
which is also commonly used as a source of 
 morsellised bone stock.
Disadvantages of bone allograft use include a re-
ported increase in susceptibility to infection (2), and 
potential for disease transmission (4). There is also 
potential for bone resorption due to immune reac-
tion (3), fracture (2), and non-union of the allo-
graft (2,5,13).
The purpose of this study is to present medium-
term clinical and radiological review of patients 
who received allograft bone in complex cases of 
 revision TKA presenting with bone defects. 
PATIENTS AND METHODS
Between 1994 and 2009, 33 revision TKA procedures 
using allograft bone were performed in 30 patients. All 
operations were performed at one hospital by the senior 
author (DAFM). Three patients were excluded from the 
study, as follow-up Knee Society Score (KSS) score had 
not been calculated prior to their deaths. It is noted 
 however that patients’ graft survival was 1 year, 7 years 
and 8 years respectively with no plan for further surgical 
management. Hence, follow-up was performed on 30 re-
vision TKA procedures in 27 patients. 
Aseptic loosening of primary knee replacement was 
the reason for 29 revision surgeries, and one revision was 
performed following aseptic loosening of a unicompart-
mental knee replacement. Minimum follow-up was 
1 year, with the average of 5 years (1-14 years) (Table I). 
The average age at time of surgery was 72.1 years (60-
85 years). One patient was lost to follow-up after one 
year, and hence was regarded as a failed procedure. Re-
view of the Australian National Joint Registry did not 
reveal further revision surgery for this patient. 
Bone defects were classified using the Anderson 
 Orthopaedic Research Institute (AORI) bone defect 
 classification (7) (Fig. 1). Preoperatively, 13 knees (43%) 
Table I. — Clinical characteristics of 27 patients who had revision TKA with bone allograft augmentation
Clinical characteristics Number
Age at time of surgery 72.1 year (60-85 years)
Follow-up time 5 years (1-14 years)
Gender Male 12
Female 15
Surgical side left 14
right 16
Anderson Orthopaedic Research Institute classification AORI 1 13          (43%)
AORI 2a 6            (20%)
AORI 2b 2            (7%)
AORI 3 9            (30%)
Bone defect Femoral and Tibial 11          (37%)
Tibial alone 18          (60%)
Femoral alone 1            (3%)
Allograft type morsellised 21          (70%)
bulk 9            (30%)
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were classified as type 1 defects, 6 knees (20%) as type 
2a defects, 2 knees (7%) as type 2b defects and 9 knees 
(30%) as type 3 defects (Fig. 2, 3). Eighteen knees (60%) 
presented with isolated tibial bone defects, 11 knees 
(37%) had both tibial and femoral bone loss, and 1 knee 
(3%) had an isolated femoral bone defect. Morsellised 
allograft was used in 21 (70%) cases. In 2 (22%) of these 
cases, structural allograft was used to reconstruct both 
tibial and femoral defects, in 6 (66%) cases, structural 
allograft was used to reconstruct tibial defects, and in 
1 case (11%), structural allograft was used to reconstruct 
femoral defects (Fig. 4, 5). The total number of structural 
allografts used was 11. 
All allografts were sourced from the Queensland Bone 
Bank, which complies with all standards of the American 
Association of Tissue Banks (17) and with the code of 
good manufacturing of the Therapeutic Goods Adminis-
tration (TGA) in Australia. All allografts were sterilized 
using gamma irradiation (25 +/- 5 kGy). 
Surgical technique
The knee was approached via a medial parapatellar 
approach using the previous skin incision. After adequate 
exposure, the failed implants were removed along with 
nonviable bone and necrotic tissue, until a healthy, bleed-
ing tissue bed was achieved. Five separate tissue samples 
were taken and sent for testing, to ensure there was no 
infection. The bone defects were then re-assessed and the 
type of allograft needed was determined. Structural 
Fig. 1. — Anderson Orthopaedic Research Institute (AORI) classification system (Engh 1997). Type F1-intact metaphyseal cortical 
bone, femur. Type T1-intact metaphyseal cortical bone, tibia. Type F2A-damaged metaphyseal cortical bone, femur, unicondylar. Type 
F2B-damaged metaphyseal cortical bone, femur, bicondylar. Type T2A-damaged metaphyseal cortical bone, tibia, one plateau. Type 
T2B-damaged metaphyseal cortical bone, tibia, two plateaus. Type F3-deficient metaphyseal cortical bone, with major loss of femoral 
condyle. Type T3-deficient metaphyseal cortical bone, with major loss of tibial plateau. (Permission granted to use these image from 
Nova Science Publishers, Inc).
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Fig. 4. — Post operative anteroposterior (A) and lateral (B) 
radiographs showing a revision with tibial allograft-implant 
composite. The tibial tubercle osteotomy is reattached to the 
allograft with a screw. (Permission granted to use these images 
from Nova Science Publishers, Inc).
Fig. 2. — Preoperative anteroposterior (A) and lateral (B) ra-
diographs of a right knee demonstrating an AORI type-3 tibial 
defect. (Permission granted to use these images from Nova 
 Science Publishers, Inc).
Fig. 5. — Anteroposterior (A) and lateral (B) radiographs 
showing a revision with femoral allograft-implant composite. 
The epicondyles are reattached to the allograft with screws. 
(Permission granted to use these images from Nova Science 
Publishers, Inc).
Fig. 3. — Preoperative anteroposterior (A) and lateral (B) ra-
diographs of a right knee demonstrating an AORI type-3 femo-
ral defect obtained eight years after revision TKA using a prox-
imal tibial allograft. Note union of the allograft to host bone and 
no signs of loosening of the tibial implant. (Permission granted 
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19 knees (63%) were graded as “excellent”, 4 knees 
(13%) were graded as “good”, 1 knee (3%) was 
graded as “fair”, and 6 knees (20%) were graded as 
“poor”. The average post operative KSS was 76.4 
with a range of 0 (patient lost to follow-up) to 99. 
A revision-free survival was calculated as 93% at 
5 years (95% confidence interval 0.765-0.988) and 
57% at 10 years (95% confidence interval 0.378-
0.742) (Fig. 6). 
Three knees were re-revised for aseptic loosen-
ing. Of them, one knee (AORI T3, F3 defects ; 
structural allograft to tibia and femur) required fur-
ther surgery at one year for aseptic loosening of the 
femoral component. At 6 years, the patients KSS 
was 95 points. One knee (AORI T3, structural al-
lograft) had further surgery at 6 years using struc-
tural  allografts to both tibia and femur. At 10 years 
post re-revision, the KSS was 90 points. One patient 
(AORI T3, F1 defects ; structural allograft to tibia, 
morsellised graft to femur) presented with loosen-
ing of the femoral component at 8 years. Structural 
allograft was used to manage the femoral defect. 
The KSS was 60 points at 6 years. 
Radiolucencies around the medial tibial plateau 
in one knee (AORI T2a, morsellised graft) at 3 years 
after the revision was noted. The patient was 
 asymptomatic and had a KSS of 88 points.
Complications were encountered in 7 cases 
(23%) (Table II). Three patients presented with late 
 allograft was then brought into the operating room, sam-
ples were taken for bacteriologic studies and the allograft 
was immersed in warm Betadine solution to thaw. The 
level of joint line was then determined from intact host 
bone. The host femoral and/or tibial canals were reamed 
until a good press fit of the trial stem was achieved. With 
the trial implants in place, the amount of bone loss was 
evaluated and the size of allograft calculated. The 
 allograft was fashioned to size on a standard cutting jig. 
Grafts were oversized and then trimmed as necessary. A 
step cut osteotomy of the host bone at the host allograft 
junction was performed, which assisted in maintaining 
rotational stability and increased the host-allograft con-
tact surface area. Fixation of the implant to the allograft 
was achieved using cementing methods. The stem was 
then inserted into the prereamed tibial or femoral medul-
lary canal, and the allograft-implant composite was fitted 
to host bone. For contained defects, morsellised bone 
was prepared from thawed femoral head using a bone 
mill, and was then press fit into defects as required, 
 before the fitting of new implants. Leg length, patella 
tracking, ROM and knee tension were assessed. Wounds 
were then thoroughly washed with pulse lavage, and the 
knee was closed in layers over a drain. Postoperatively, 
ROM exercises were commenced as soon as possible af-
ter the surgery. Protected weight bearing was maintained 
until there were radiological signs of union between the 
host and allograft bone. 
Patients were reviewed by an independent investigator 
not involved in the surgical procedure (KFF). They were 
assessed using the KSS (11), where a KSS score of 80 to 
100 was considered as excellent, a score of 70 to 79 was 
considered as good, a score of 60 to 69 was considered as 
fair, and a score below 60 was considered as poor. Range 
of motion was measured using a goniometer. Radio-
graphs were analyzed for signs of loosening, implant mi-
gration, graft resorption, graft fracture and graft fragmen-
tation. Joint alignment measurements were also made on 
radiographs to assist with calculation of the anatomical 
axis for KSS. 
Survivorship analysis was performed using Kaplan-
Meier survivorship curves and 95% confidence intervals 
were identified at 5 and 10 years post operatively with 
the need for re-revision of the implant or the allograft 
considered as end point.
RESULTS
The patients were followed for a mean of 5 years 
(1-14 years). At the last review, using the KSS, 
Fig. 6. — Kaplan-Meier Survivorship curve for revision TKR 
with allograft with confidence intervals.
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contribute to this. Firstly, the aged patient demo-
graphic, with revision surgery typically performed 
in the 8th decade of life contributes greatly to diffi-
culties with long term follow-up. In addition, revi-
sion TKA together with allograft use is an uncom-
mon procedure. The National Joint Registry for 
England and Wales for the year 2007 recorded 
65,532 TKR of which 3,320 (5%) were revision 
procedures (12). Review of the Australian National 
Joint Replacement Registry, shows there were 
380,726 knee replacement procedures recorded be-
tween 1/9/1999 and 31/12/2011. Of these, 16,420 
(4.3%) were recorded as revision procedures. This 
included major total, major partial and minor revi-
sion procedures. Not all of these would have had 
large bone defects, and those that did, may have 
been managed in ways other than allograft use. 
A review of the current literature published in 
English speaking journals, shows that a number of 
studies have been performed where bone allograft 
has been used in revision TKA. Reported survival 
rates of revision TKR with allograft bone ranges 
 between 67% and 86% with follow-up ranging 
 between 5 and 10 years (2,5,6,9,12). These studies 
suggest that the use of structural allograft for bone 
defects in revision TKA is a viable option.
We recognize certain limitations to our study. 
Firstly, it is a relatively small study size, with only 
30 revision surgeries. Our study grouped all al-
lograft use together, not differentiating cases with 
morsellised graft from the more complex cases 
managed with structural allograft. This was done to 
increase the study size, but has made direct com-
parison with other studies difficult. Our follow-up 
time has also been limited. Although the average 
follow-up time is 5 years, with a range of 1-14 years, 
in 15 cases (50%) it has been 4 years or less. In the 
majority of cases, review was conducted by a single 
independent interviewer who was not involved with 
the surgery. A small group of patients, due to dis-
tance (often residing up to 1200 km from treatment 
location), underwent telephone interview and clini-
cal review by their local General Practitioners. This 
may lead to some variability in results. Unfortunate-
ly, preoperative Knee Society scores were not 
 routinely recorded for all patients, eliminating the 
ability to make direct clinical comparisons with 
infections (at 2, 6 and 7 years). Of them, one patient 
was managed with a two-stage revision (KSS 
89 points at 6 months), one patient was managed 
with a knee arthrodesis (KSS 75 points at 4 years), 
and one patient is being managed with suppressive 
antibiotic treatment for a chronic discharging sinus.
In one case, evacuation of a post-operative hae-
matoma was required. One patient presented with 
quadriceps tendon rupture 10 weeks post surgery, 
which was primarily repaired. At last review, the 
patient had full range of motion of the knee with no 
extensor lag. One patient developed a symptomatic 
DVT and PE 3 years following his surgery. The pa-
tient was not treated at our facility and the details 
surrounding this presentation are limited. One pa-
tient underwent further surgery with supplemental 
morsellised bone allograft at one year for a non-
union between structural allograft and host bone. 
DISCUSSION
Patients undergoing revision TKA may present 
with large osseous defects. These commonly occur 
secondary to osteolysis, implant migration, implant 
loosening or from multiple revisions. Addressing 
these deficiencies is necessary to enable stable im-
plant fixation at time of revision surgery. Allograft 
use offers an option to reconstruct bone deficien-
cies ; however, it is technically demanding. In this 
study, both morsellised and structural allograft were 
used to reconstruct bone deficiencies present at the 
time of revision TKA. 
There is reasonably limited data published in the 
English literature on the use of bone allograft in re-
vision TKA. The majority of these studies comment 
on outcome in the short to medium term, but there is 
a paucity of data for long term results. A few factors 
Table II. — Complication breakdown
Complication Number
Joint infection 3     (10%)
Haematoma requiring evacuation 1     (3.3%)
Quadriceps tendon rupture 1     (3.3%)
Non union 1     (3.3%)
Symptomatic DVT 1     (3.3%)
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cern. Three patients (10%) in our study presented 
with late infection. In all cases, infection manifested 
beyond 2 years from the index revision TKA. Al-
though high, this rate is comparable to other studies. 
Rates of infection were reported to range between 0 
and 10% with the use of allografts in revision 
TKA (1,2,5,7,9). Infection rate in non allograft revi-
sion total knee replacement has been reported as 
0-4.5%, which is significantly lower than infection 
risk in revision surgery with allograft bone use (5,9). 
In summary, our findings suggest that structural 
bone allograft use is a viable option in complex re-
vision TKA with major bone loss. Increased patient 
numbers and extended follow-up of patients over 
the next few years will allow medium and long-term 
outcomes to be assessed with more weight.
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